General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold
- PMID: 19010777
- DOI: 10.1074/jbc.M806889200
General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold
Abstract
Nanobodies, single-domain antigen-binding fragments of camelid-specific heavy-chain only antibodies offer special advantages in therapy over classic antibody fragments because of their smaller size, robustness, and preference to target unique epitopes. A Nanobody differs from a human heavy chain variable domain in about ten amino acids spread all over its surface, four hallmark Nanobody-specific amino acids in the framework-2 region (positions 42, 49, 50, and 52), and a longer third antigen-binding loop (H3) folding over this area. For therapeutic applications the camelid-specific amino acid sequences in the framework have to be mutated to their human heavy chain variable domain equivalent, i.e. humanized. We performed this humanization exercise with Nanobodies of the subfamily that represents close to 80% of all dromedary-derived Nanobodies and investigated the effects on antigen affinity, solubility, expression yield, and stability. It is demonstrated that the humanization of Nanobody-specific residues outside framework-2 are neutral to the Nanobody properties. Surprisingly, the Glu-49 --> Gly and Arg-50 --> Leu humanization of hallmark amino acids generates a single domain that is more stable though probably less soluble. The other framework-2 substitutions, Phe-42 --> Val and Gly/Ala-52 --> Trp, are detrimental for antigen affinity, due to a repositioning of the H3 loop as shown by their crystal structures. These insights were used to identify a soluble, stable, well expressed universal humanized Nanobody scaffold that allows grafts of antigen-binding loops from other Nanobodies with transfer of the antigen specificity and affinity.
Similar articles
-
In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.J Nucl Med. 2010 Jul;51(7):1099-106. doi: 10.2967/jnumed.109.069823. Epub 2010 Jun 16. J Nucl Med. 2010. PMID: 20554727
-
A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops.Structure. 1999 Apr 15;7(4):361-70. doi: 10.1016/s0969-2126(99)80049-5. Structure. 1999. PMID: 10196124
-
Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies.J Mol Recognit. 1999 Mar-Apr;12(2):131-40. doi: 10.1002/(SICI)1099-1352(199903/04)12:2<131::AID-JMR454>3.0.CO;2-M. J Mol Recognit. 1999. PMID: 10398404
-
Single domain camel antibodies: current status.J Biotechnol. 2001 Jun;74(4):277-302. doi: 10.1016/s1389-0352(01)00021-6. J Biotechnol. 2001. PMID: 11526908 Review.
-
Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.Curr Pharm Des. 2016;22(43):6500-6518. doi: 10.2174/1381612822666160923114417. Curr Pharm Des. 2016. PMID: 27669966 Review.
Cited by
-
Development of a CD39 nanobody and its enhancement to chimeric antigen receptor T cells efficacy against ovarian cancer in preclinical studies.Theranostics. 2024 Sep 30;14(16):6249-6267. doi: 10.7150/thno.97590. eCollection 2024. Theranostics. 2024. PMID: 39431011 Free PMC article.
-
Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.J Extracell Vesicles. 2021 Feb;10(4):e12057. doi: 10.1002/jev2.12057. Epub 2021 Feb 16. J Extracell Vesicles. 2021. PMID: 33643546 Free PMC article.
-
Humanization of the antigen-recognition domain does not impinge on the antigen-binding, cytokine secretion, and antitumor reactivity of humanized nanobody-based CD19-redirected CAR-T cells.J Transl Med. 2024 Jul 25;22(1):679. doi: 10.1186/s12967-024-05461-8. J Transl Med. 2024. PMID: 39054481 Free PMC article.
-
Single-domain antibodies against SARS-CoV-2 RBD from a two-stage phage screening of universal and focused synthetic libraries.BMC Infect Dis. 2024 Feb 13;24(1):199. doi: 10.1186/s12879-024-09022-8. BMC Infect Dis. 2024. PMID: 38350843 Free PMC article.
-
Reprogramming human B cells with custom heavy-chain antibodies.Nat Biomed Eng. 2024 Dec;8(12):1700-1714. doi: 10.1038/s41551-024-01240-4. Epub 2024 Jul 22. Nat Biomed Eng. 2024. PMID: 39039240
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases